Your browser doesn't support javascript.
loading
Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [18F]FDG PET/CT Imaging and Clinical Features.
Dirks, Ine; Keyaerts, Marleen; Dirven, Iris; Neyns, Bart; Vandemeulebroucke, Jef.
Afiliação
  • Dirks I; Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
  • Keyaerts M; IMEC, 3001 Leuven, Belgium.
  • Dirven I; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
  • Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
  • Vandemeulebroucke J; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
Cancers (Basel) ; 15(16)2023 Aug 13.
Article em En | MEDLINE | ID: mdl-37627111
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica